0000000000701943

AUTHOR

Vesna Zadnik

showing 6 related works from this author

Burden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases S…

2022

Background: Disability and mortality burden of non-communicable diseases (NCDs) have risen worldwide; however, the NCD burden among adolescents remains poorly described in the EU. Methods: Estimates were retrieved from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Causes of NCDs were analysed at three different levels of the GBD 2019 hierarchy, for which mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) were extracted. Estimates, with the 95% uncertainty intervals (UI), were retrieved for EU Member States from 1990 to 2019, three age subgroups (10–14 years, 15–19 years, and 20–…

Malemortality burdenAdolescentRJRJ101CareGlobal Burden of DiseaseLife ExpectancyRJ101 Child Health. Child health servicesSDG 3 - Good Health and Well-beingRA04213123 Gynaecology and paediatricsRisk FactorsRA0421 Public health. Hygiene. Preventive MedicineDevelopmental and Educational PsychologyHumansDisabled PersonsNoncommunicable DiseasesFutureDeterminantsMCCDisabilityPublic Health Global Health Social Medicine and EpidemiologyBurden of non-communicable diseases among adolescents aged 10–24 years in the EU 1990–2019: a systematic analysis of the Global Burden of Diseases Study 20193rd-DASDisability; mortality burdenFolkhälsovetenskap global hälsa socialmedicin och epidemiologin/aHealthPediatrics Perinatology and Child HealthFemaleRA
researchProduct

Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease St…

2022

Correction to Lancet Gastroenterol Hepatol 2022; 7: 627-47. Lancet Gastroenterol Hepatol. 2022 Aug;7(8):704. doi: 10.1016/S2468-1253(22)00210-2. PMID: 35809605. Background: Colorectal cancer is the third leading cause of cancer deaths worldwide. Given the recent increasing trends in colorectal cancer incidence globally, up-to-date information on the colorectal cancer burden could guide screening, early detection, and treatment strategies, and help effectively allocate resources. We examined the temporal patterns of the global, regional, and national burden of colorectal cancer and its risk factors in 204 countries and territories across the past three decades. Methods: Estimates of incidenc…

AdultMED/42 - IGIENE GENERALE E APPLICATAIMPACTcolorectal cancerColorectal NeoplasmGBD 2019 Colorectal Cancer CollaboratorsHEREDITARYGlobal Burden of DiseaseCancer screeningDISPARITIESSDG 3 - Good Health and Well-beingCancer treatment strategiesRisk FactorsQuality-Adjusted Life YearCOLONGlobal studiesDALY GBD colorectal cancerrisk factorsHumansGlobal Burden of Disease StudyEarly Detection of CancerHepatologyMORTALITYGastroenterologyCancer incidence ratesMiddle AgedCancer burdenSURVIVAL/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSEXGENDERQuality-Adjusted Life YearsColorectal NeoplasmsHumanThe Lancet Gastroenterology & Hepatology
researchProduct

Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years

2019

ObjectiveThe incidence of colorectal cancer (CRC) declines among subjects aged 50 years and above. An opposite trend appears among younger adults. In Europe, data on CRC incidence among younger adults are lacking. We therefore aimed to analyse European trends in CRC incidence and mortality in subjects younger than 50 years.DesignData on age-related CRC incidence and mortality between 1990 and 2016 were retrieved from national and regional cancer registries. Trends were analysed by Joinpoint regression and expressed as annual percent change.ResultsWe retrieved data on 143.7 million people aged 20–49 years from 20 European countries. Of them, 187 918 (0.13%) were diagnosed with CRC. On averag…

AdultMalemedicine.medical_specialtyJoinpoint regressionColorectal cancerYoung Adult03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingRegional cancerEpidemiologyHumansMedicineYoung adultRetrospective Studiesbusiness.industryIncidenceIncidence (epidemiology)GastroenterologyMiddle Agedmedicine.diseaseAnnual Percent Change3. Good healthEuropeSurvival RateYounger adults030220 oncology & carcinogenesisFemale030211 gastroenterology & hepatologyColorectal NeoplasmsbusinessFollow-Up StudiesForecastingDemographyGut
researchProduct

Completeness and timeliness: Cancer registries could/should improve their performance.

2015

Abstract Cancer registries must provide complete and reliable incidence information with the shortest possible delay for use in studies such as comparability, clustering, cancer in the elderly and adequacy of cancer surveillance. Methods of varying complexity are available to registries for monitoring completeness and timeliness. We wished to know which methods are currently in use among cancer registries, and to compare the results of our findings to those of a survey carried out in 2006. Methods In the framework of the EUROCOURSE project, and to prepare cancer registries for participation in the ERA-net scheme, we launched a survey on the methods used to assess completeness, and also on t…

CompletenessCancer ResearchTime FactorsCancer registry Completeness Timeliness Flow methodPopulationFlow methodDeath CertificatesNOMedian latencyCause of DeathNeoplasmsMedicineHumansRegistrieseducationeducation.field_of_studybusiness.industryInformation DisseminationData CollectionIncidenceComparabilityTimelinessFlow methodCancer registrymedicine.diseaseQuality ImprovementCancer registryEuropeOncologyPopulation SurveillanceMedical emergencyDeath certificatebusinessCompleteness (statistics)European journal of cancer (Oxford, England : 1990)
researchProduct

Changes in disease burden in Poland between 1990-2017 in comparison with other Central European countries: A systematic analysis for the Global Burde…

2020

Background Systematic collection of mortality/morbidity data over time is crucial for monitoring trends in population health, developing health policies, assessing the impact of health programs. In Poland, a comprehensive analysis describing trends in disease burden for major conditions has never been published. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides data on the burden of over 300 diseases in 195 countries since 1990. We used the GBD database to undertake an assessment of disease burden in Poland, evaluate changes in population health between 1990–2017, and compare Poland with other Central European (CE) countries. Methods The results of GBD 2017 for …

MaleSystems AnalysisPulmonology030204 cardiovascular system & hematologyGlobal HealthPathology and Laboratory MedicineGeographical locationsGlobal Burden of DiseaseSelf Harm0302 clinical medicineEndocrinologySex factorsRisk FactorsGlobal healthMedicine and Health SciencesMedicinePublic and Occupational Health030212 general & internal medicineChild2. Zero hungerAged 80 and overMultidisciplinaryOrganic CompoundsQ1. No povertyRMiddle Aged3. Good healthEuropeChemistryChild PreschoolPhysical SciencesMedicineFemaleQuality-Adjusted Life YearsResearch ArticleBurden of diseaseAdultCross-Cultural ComparisonAdolescentEndocrine DisordersChronic Obstructive Pulmonary DiseaseScienceLower Back PainMEDLINEPainPopulation health03 medical and health sciencesYoung AdultSigns and SymptomsLife ExpectancySex FactorsDiagnostic MedicineEnvironmental healthburden of disease Poland epidemiologyMental Health and PsychiatryDiabetes MellitusHumansEuropean UnionDisease burdenAgedbusiness.industryMortality PrematureOrganic ChemistryChemical CompoundsInfant NewbornInfantQuality-adjusted life yearAlcoholsMetabolic DisordersPolandPeople and placesbusinessPLoS ONE
researchProduct

Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCO…

2022

BACKGROUND Leukaemias comprise a heterogenous group of haematological malignancies. In CONCORD-3, we analysed data for children (aged 0-14 years) and adults (aged 15-99 years) diagnosed with a haematological malignancy during 2000-14 in 61 countries. Here, we aimed to examine worldwide trends in survival from leukaemia, by age and morphology, in young patients (aged 0-24 years). METHODS We analysed data from 258 population-based cancer registries in 61 countries participating in CONCORD-3 that submitted data on patients diagnosed with leukaemia. We grouped patients by age as children (0-14 years), adolescents (15-19 years), and young adults (20-24 years). We categorised leukaemia subtypes a…

AdolescentAustralia610 Medicine & healthlymphomaSettore MED/42 - Igiene Generale E ApplicatasurvivalUnited StatesEuropeLeukemia Myeloid AcuteYoung Adultchildrenpopulation-based/cancer registry360 Social problems & social servicessurvival leukemia cancer registryHematologic NeoplasmsleukaemiaPediatrics Perinatology and Child HealthDevelopmental and Educational PsychologycancerHumansRegistrieshaematological malignancy610 Medicine & healthChild360 Social problems & social services
researchProduct